Anesth Analg 1999;88:980-984
© 1999 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Treatment of Intraoperative Refractory Hypotension with Terlipressin in Patients Chronically Treated with an Antagonist of the Renin-Angiotensin System
Daniel Eyraud, MD,
Steven Brabant, MD,
Dieudonne Nathalie, MD,
Marie-Hélène Fléron, MD,
Godet Gilles, MD,
Michèle Bertrand, MD, and
Peirre Coriat, MD
Department of Anesthesiology and Critical Care, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Address correspondence and reprint requests to Dr. Daniel Eyraud, Department d'Anesthésie-Réanimation, Groupe Hospitalier Pitié-Salpêtrière, 47 Blvd. de l'Hôpital, 75651 Paris Cedex, France.
The goal of the present study was to determine whether terlipressin, an agonist of the vasopressin system, could counteract perioperative hypotension refractory to common vasopressor therapy and to analyze its circulatory effects. We enrolled 51 consecutive vascular surgical patients chronically treated with angiotensin-converting enzyme inhibitors or antagonists of the receptor of angiotensin II, who received a standardized opioid-propofol anesthetic. Of these 51 patients, 32 had at least one episode of hypotension, which responded to epinephrine or phenylephrine. In 10 other patients, systolic arterial pressure (SAP) did not remain above 100 mm Hg for 1 min, despite three bolus doses of ephedrine or phenylephrine. In these patients, we injected a bolus of 1 mg of terlipressin, repeated twice if necessary. Hemodynamic and echocardiographic variables were recorded every 30 s over 6 min. In eight patients, arterial pressure was restored with one injection of terlipressin; in two other patients, three injections were necessary. One minute after the last injection of terlipressin, the SAP increased from 88 ± 3 to 100 ± 4 mm Hg and reached 117 ± 5 mm Hg (P = 0.001) 3 min after the injection and remained stable around this value. This increase in SAP was associated with significant changes in left ventricular end-diastolic area (17.9 ± 2 vs 20.2 ± 2.2 cm2; P = 0.003), end-systolic area (8.1 ± 1.3 vs 9.6 ± 1.5 cm2; P = 0.004), end-systolic wall stress (45 ± 8 vs 66 ± 12; P = 0.001), and heart rate (60 ± 4 vs 55 ± 3 bpm; P = 0.001). Fractional area change and velocity of fiber shortening did not change significantly. No additional injection of vasopressor was required during the perioperative period. No change in ST segment was observed after the injection.
Implications: Terlipressin is effective to rapidly correct refractory hypotension in patients chronically treated with antagonists of the renin-angiotensin system without impairing left ventricular function.
This article has been cited by other articles:

|
 |

|
 |
 
A. Noto, S. Lentini, A. Versaci, M. Giardina, D. C. Risitano, R. Messina, and A. David
A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery
Interactive CardioVascular and Thoracic Surgery,
October 1, 2009;
9(4):
588 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Groban and J. Butterworth
Perioperative management of chronic heart failure.
Anesth. Analg.,
September 1, 2006;
103(3):
557 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Dunser, A. J. Mayr, H. Ulmer, H. Knotzer, G. Sumann, W. Pajk, B. Friesenecker, and W. R. Hasibeder
Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study
Circulation,
May 13, 2003;
107(18):
2313 - 2319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Coriat
Renin Angiotensin Aldosterone Systems Blockade and PerioperativeLeft Ventricular Function
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2003;
7(1):
55 - 58.
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ryckwaert, P. Colson, E. Andre, P.-F. Perrigault, G. Guillon, and C. Barberis
Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig
Br. J. Anaesth.,
October 1, 2002;
89(4):
599 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Meersschaert, L. Brun, M. Gourdin, S. Mouren, M. Bertrand, B. Riou, and P. Coriat
Terlipressin-Ephedrine Versus Ephedrine to Treat Hypotension at the Induction of Anesthesia in Patients Chronically Treated with Angiotensin Converting-Enzyme Inhibitors: A Prospective, Randomized, Double-Blinded, Crossover Study
Anesth. Analg.,
April 1, 2002;
94(4):
835 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Prys-Roberts and G. Godet
Withdrawal of Antihypertensive Drugs Before Anesthesia * Response
Anesth. Analg.,
March 1, 2002;
94(3):
767 - 768.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Medel, G. Boccara, E. Van de Steen, M. Bertrand, G. Godet, and P. Coriat
Terlipressin for Treating Intraoperative Hypotension: Can it Unmask Myocardial Ischemia?
Anesth. Analg.,
July 1, 2001;
93(1):
53 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Johnson and J. D. Tobias
Hypotension Following the Initiation of Tizanidine in a Patient Treated With an Angiotensin Converting Enzyme Inhibitor for Chronic Hypertension
J Child Neurol,
December 1, 2000;
15(12):
818 - 819.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. De Kock, P.-F. Laterre, P. Andruetto, L. Vanderessen, S. Dekrom, B. Vanderick, and P. Lavand'homme
Ornipressin (Por 8): An Efficient Alternative to Counteract Hypotension During Combined General/Epidural Anesthesia
Anesth. Analg.,
June 1, 2000;
90(6):
1301 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Colson, F. Ryckwaert, and P. Coriat
Renin Angiotensin System Antagonists and Anesthesia
Anesth. Analg.,
November 1, 1999;
89(5):
1143 - 1143.
[Full Text]
[PDF]
|
 |
|
|